Introduction
The protein tyrosine kinases (PTKs) are a large and diverse multigene family found only in Metazoans. Their principal functions involve the regulation of multicellular aspects of the organism. Cell to cell signals concerning growth, dierentiation, adhesion, motility, and death, are frequently transmitted through tyrosine kinases. In contrast, many of the serine/ threonine kinase families, such as cyclin dependent kinases and MAP kinases, are conserved throughout eukaryotes and regulate processes in both unicellular and multicellular organisms. In humans, tyrosine kinases have been demonstrated to play signi®cant roles in the development of many disease states, including diabetes and cancer. Historically, tyrosine kinases de®ne the prototypical class of oncogenes, involved in most forms of human malignancies. Tyrosine kinase genes have also been linked to a wide variety of congenital syndromes (Robertson et al., 2000) . Intensive study of this relevant gene family over the past 20 years has produced numerous insights into the structure, regulation, and function of these genes and their products. Many excellent reviews of protein tyrosine kinase structure and function have been published recently and are listed in Table 1 .
Tyrosine kinases contain highly conserved catalytic domains similar to those in protein serine/threonine and dual-speci®city kinases but with unique subdomain motifs clearly identifying members as tyrosine kinases (Hanks and Quinn, 1991) . The high degree of conservation of the tyrosine kinase motifs has allowed the identi®cation of tyrosine kinase genes in most metazoan phyla. Tyrosine kinase genes have been characterized in poriferans, cnidarians, nematodes, annelids, arthropods, echinoderms, and chordates (Suga et al., 1999; Muller et al., 1999; Miller et al., 2000; Rikke et al., 2000; Lucini et al., 1999; Sakuma et al., 1997) . These sequences provide an extensive set of probes to investigate the genomic sequences of other species. Protein kinase catalogs of Saccharomyces cerevesiae, Caenorhabditis elegans, and Drosophila melanogaster have been compiled from the completed genomic sequences of these organisms (Hunter and Plowman, 1997; Plowman et al., 1999; Popovici et al., 1999; Morrison et al., 2000) . Thanks to the eorts of all involved in the Human Genome Project, the draft sequence of the euchromatic regions of the human genome is nearly complete, an achievement of immeasurable signi®cance. The accessibility of this vast information to researchers in the biological sciences should greatly facilitate further advances. The large well-studied family of protein tyrosine kinases provides a ®tting framework for an initial analysis of the human genome sequence.
Searching the genome
To create a catalog of protein tyrosine kinase coding regions in the human genome, we performed iterative BLAST searches against the six-frame translations of the human genomic sequences available in the public databases (Altschul et al., 1990; Walchli et al., 2000) . As probes, we used the amino acid sequences from the canonical tyrosine kinase domain of known and predicted tyrosine kinase genes of vertebrates, C. elegans, and D. melanogaster. A single accession was selected for each unique sequence and the translation was examined for protein kinase motifs and reciprocal BLAST searches were done to verify the sequence had highest similarity to protein tyrosine kinases and not other protein kinase families. The results are shown in Table 2a and b. The human genome, as currently sequenced, contains 90 tyrosine kinase genes and ®ve presumed tyrosine kinase pseudogenes. Of the 90 tyrosine kinase genes, 58 are of the receptor type as de®ned by encoding a protein with a predicted transmembrane domain. These 58 receptor tyrosine kinases can be grouped into 20 subfamilies based on kinase domain sequence. The 32 non-receptor tyrosine kinases fall into 10 subfamilies based on kinase domain sequence. The remaining ®ve sequences are classi®ed as Hubbard and Till, 2000; Hunter, 2000; Robertson et al., 2000; Cole et al., 1999; Fischer, 1999; Schenk and Snaar-Jagalska, 1999; Hubbard et al., 1998; Porter and Vaillancourt, 1998; Johnson et al., 1996; Hanks and Hunter, 1995 Non-receptor families Neet and Hunter, 1996 ABL Lanier and Gertler, 2000 Laneuville, 1995 ACK Mott et al., 1999 CSK Sondhi and Cole, 1999 Klages et al., 1994 FAK Avraham et al., 2000 Girault et al., 1999; Schlaepfer and Hunter, 1998; Weisberg et al., 1997 FES Smithgall et al., 1998 Pendergast, 1996 FRK Lee, 1998 Vasioukhin and Tyner, 1997; Kohmura et al., 1994; Lee et al., 1994 JAK Danial and Rothman, 2000; Imada and Leonard, 2000; Aringer et al., 1999; O'Shea, 1998 SRC Abram and Courtneidge, 2000; Schlessinger, 2000; Schwartzberg, 1998; Thomas and Brugge, 1997; Chow and Veillette, 1995 TEC Schaeffer and Schwartzberg, 2000; Yang et al., 2000; Mano, 1999; Rawlings and Witte, 1995 SYK Turner et al., 2000; Chu et al., 1998 Receptor families Ullrich, 1992 ALK Ladanyi, 2000; Iwahara et al., 1997; Ladanyi, 1997 AXL Crosier and Crosier, 1997; Neubauer et al., 1997 DDR Weiner and Zagzag, 2000; Vogel, 1999; Schlessinger, 1997 EGFR Klambt, 2000 Hackel et al., 1999; Kim and Muller, 1999; Wells, 1999 EPH Mellitzer et al., 2000 Frisen et al., 1999; Holder and Klein, 1999; Bruckner and Klein, 1998; Flanagan and Vanderhaeghen, 1998; Wilkinson, 1997 FGFR Gerwins et al., 2000; Klint and Claesson-Welsh, 1999 INSR LeRoith, 2000; Whitehead et al., 2000; Baserga, 1999; Marino-Buslje et al., 1999 MET van der Voort et al., 2000 Danilkovitch and Leonard, 1999; Birchmeier and Gherardi, 1998; Comoglio and Boccaccio, 1996 MUSK Glass and Yancopoulos, 1997 PDGFR Bourette and Rohrschneider, 2000 Shurin et al., 1998 PTK7 Park et al., 1996 RET Mason, 2000 Eng, 1999; Eng and Mulligan, 1997 ROR Takeuchi et al., 2000; Forrester et al., 1999 ROS Yeung et al., 1998 Birchmeier et al., 1993 RYK Serfas and Tyner, 1998 TIE Partanen and Dumont, 1999 Tallquist et al., 1999 TRK Hallbook, 1999 Kaplan and Miller, 1997; Barbacid, 1995; 1994 VEGFR Gerwins et al., 2000 Veikkola et al., 2000; Neufeld et al., 1999 AATYK Gaozza et al., 1997 Figure 1 pseudogenes by the lack of introns in the sequence, the truncation of the coding regions compared to other members of the family, the presence of in-frame termination codons, and the absence of evidence for expression. Genomic sequences for all but ®ve of the known tyrosine kinase genes can be found in the current GenBank databases, consistent with the predicted coverage of the human genome with the present BAC (Bacterial Arti®cial Chromosome) tiling and sequencing status. This allows the possibility that a very small number of protein tyrosine kinase coding elements remain undetected at present. The information in Table 2a and b is presented in a way to facilitate access to the tools and databases at the NCBI Web site (http://www.ncbi.nlm.nih.gov). Gene symbols in the ®rst column are those most Symbols used in non-human species are followed by a species designation of (m) Mus musculus, (r) Rattus norvegicus, and (ch) Gallus gallus. Gene symbols in bold are those approved by HUGO Gene Nomenclature Committee (White et al., 1997) . These approved symbols are used in the LocusLink curated database of linked information on de®ned genes Pruitt et al., 2000) . Where possible, reference sequences (RefSeq) accession numbers are given for nucleotide and protein sequences. Unigene cluster numbers are given for access to Unigene EST database and related expression links (Boguski and Schuler, 1995) . Genomic accession numbers can be used in conjunction with Mapviewer for graphical access to the human genome data.
Newly identi®ed human tyrosine kinases
Five novel human kinase sequences were identi®ed in the genome-wide search. The ®rst is the human ortholog of the EphA6 gene of rodents. Interestingly, the human transcript as de®ned by several ESTs contains a truncated reading frame produced by a cryptic splice in kinase subdomain VIII. The genomic locus con®rms the validity of the EST transcripts and contains putative unused exons for subdomains IX ± XI. Whether the altered human EPHA6 gene product retains tyrosine kinase activity is an open question. A second potential new member of the Eph family is found on chromosome 1 and is designated as EPHX. The EPHX sequences in the genome retain the basic intron/exon structure of the Eph family kinase domains, and the predicted protein sequence is similar to the other members of the Eph family, although Another novel sequence uncovered, AATYK3, is a third member of a class of tyrosine kinases de®ned by the AATYK and KIAA1079 genes. AATYK3 is highly similar to the other members of the family in both kinase and non-kinase domains. The fourth novel sequence is the human ortholog of the murine Srms non-receptor tyrosine kinase and the predicted reading frame encodes a protein with high similarity to Srms in both kinase and non-kinase domains. Finally, a novel sequence with tyrosine kinase homology is found on chromosome 12 and a partial cDNA sequence exists, DKFZp761P1010. The predicted reading frame encodes a protein with weak similarity to the kinase domains of ®broblast growth factor receptors, a transmembrane domain, but lacking a signal peptide.
No other potential members of this class of tyrosine kinases were detected in the human genome. There are several tyrosine kinases found in other species for which human orthologs could not be found. The large Kin 15/Kin 16 class of receptor tyrosine kinase genes in the C. elegans genome has no identi®able orthologs in the human genome. In chickens, the src family member Yrk and the eph family member EphB5 (Cek9) lack identi®ed mammalian orthologs. One possibility is that the EPHX sequences in the human genome are from the ancestral EphB5 gene. Finally, no sequences for the proposed human ZRK zona pelucida kinase can be detected in the human genome and the ZRK clone is most likely derived from the human MER gene (Tsai and Silver, 1996) .
Distribution of human tyrosine kinase genes
The cytogenetic distribution of tyrosine kinase genes in the human genome is depicted in Figure 1 . Tyrosine kinase genes can be found on 19 of the 24 human chromosomes. At least three locations show evidence of more recent gene duplication events. On chromosome 5, the highly similar PDGFRB and CSF1R genes are adjacent and contained within a single BAC clone. On chromosome 20, the FRK family members BRK and SRMS are contained within a single BAC. On chromosome 4, the TEC and TXK genes can also be found within a single BAC clone.
Classi®cation of human tyrosine kinases
A phylogenetic analysis of the amino acid sequences of the kinase domains from the identi®ed human tyrosine kinases is shown in Figure 2 . The human tyrosine kinases may be grouped into 20 receptor and 10 nonreceptor classes as marked on the right of the ®gure. Grouping tyrosine kinase genes by intron/exon structure closely parallels the results obtained from phylogenetic sequence analysis. For example, phylogenetic analysis of amino acid sequence places the two CSK family members apart from the three FRK family members and the eight SRC family members, even though all three families share the same overall protein domain structure (Figure 3a) (Lee et al., 1998) . This distinction of the families is veri®ed by a dierent intron/exon organization for each family. Within a tyrosine kinase family, the members of a single family exhibit a common intron/exon pattern, distinct from other families.
The clustering of tyrosine kinase genes into families based on kinase domain sequence also parallels the overall domain structure of the proteins. A diagram of the overall protein domain structure of a representative member of each tyrosine kinase family is shown in Figure 3a ,b. The human tyrosine kinase families exhibit a wide spectrum of protein domains consistent with the numerous and varied interactions and functions of these molecules as reviewed by the publications in Table 1 . The domain representations are not complete. Many families encode proteins for which some domains are not de®ned, given the current state of knowledge.
Mouse orthologs of human tyrosine kinase genes
The assignment of vertebrate orthologs to the human tyrosine kinase genes was done by reciprocal BLAST Figure 2 Phylogram of the human protein tyrosine kinase family inferred from amino acid sequences of the kinase domains. The tree is constructed by the N-J method (Saitou and Nei, 1987) and the evolutionary distance is calculated by Tamura-Nei algorithm (Tamura and Nei, 1993) . Numbers on each node indicate the evolutionary distance. The tree is drawn to scale and is midpointrooted Figure 3 Domain structures of the human non-receptor tyrosine kinases (a) and receptor tyrosine kinases (b). Data were obtained by searching the amino acid sequences of the human tyrosine kinases against the latest version (5.5) of the Pfam database (Bateman et al., 2000) . Domains sharing signi®cant homologies to the Pfam-A alignments are used in this study. The schematics are shown to scale Oncogene Human tyrosine kinase family DR Robinson et al searches between the human, mouse, rat, and chicken sets of tyrosine kinase genes. Pairs with reciprocal best scores were assigned as orthologs and the results are shown in Table 3a and b (Walchi et al., 2000) . The mouse gene symbols used are in accordance with the MGD Nomenclature Committee and LocusLink (Blake et al., 2000) . The per cent identity and similarity for the protein kinase domains of the mouse and human orthologs are shown in the fourth column. Cluster numbers for the murine Unigene EST database are given. Accession numbers for identi®ed rat and chicken orthologs complete the tables. A nearly complete correspondence between the tyrosine kinase families of man and mouse exists. There are only three human PTKs for which an orthologous murine sequence has not been discovered, and this gap is likely to be ®lled quickly. Conversely, there are no identi®ed rodent tyrosine kinases for which a human ortholog does not exist. For the non-mammalian vertebrates, such as chicken, a limited number of tyrosine kinases may not have human orthologs, as discussed previously. This correspondence between the tyrosine kinase gene families of humans and mice reinforces the validity of mouse models for human diseases, especially cancer.
The application of the human genomic sequence information should greatly aid the study of protein tyrosine kinases. As a ®rst step, the catalog of tyrosine kinase genes in the human genome should provide a foundation for further discovery of kinase involvement in disease progression and functional characterizations. The fact that the range of human protein tyrosine kinases was nearly identi®ed prior to the genomic sequence information is a testament to the interest shown and quality of work performed by the numerous researchers devoted to protein kinases. Other less wellstudied gene families are likely to have more surprises in the human genome. Continuing studies on expression patterns, functional characterizations, and disease associations of tyrosine kinases, as well as studies of genetic variations at tyrosine kinase loci, should provide a basis for the development of new therapeutics for the treatment of human disease.
